Interestingly, reduced levels of SYT1 and SNAP-25 in cortical regions of the AD brain suggested that a group of synaptic proteins that include different regions of the synaptic unit would be useful in clinical research on the significance of synaptic degeneration and dysfunction in AD pathogenesis. This evidence concerns the gene SYT1 and Alzheimer disease.